How to administer an injection
The rationale is straightforward: these peptides work through complementary mechanisms, and together they may address more aspects of disc healing than either can alone
This blend contains CJC-1295 without DAC (no Drug Affinity Complex moiety)
human bioavailability is unknown Subcutaneous injection Human subcutaneous bioavailability and pharmacokinetics are unknown Factor Convenience Oral capsules No mixing or syringe math Subcutaneous injection Requires reconstitution, sterile supplies, and injection-site planning Factor Evidence limits Oral capsules No controlled human dose, benefit, or safety trial Subcutaneous injection No controlled human dose, benefit, or safety trial Factor Can the amounts be treated as equal
Baseline liver function[1]
While more large-scale human studies are needed, current research and clinical use suggest that BPC-157 is well tolerated and low-risk when used under medical supervision